Correlation Between Sangamo Therapeutics and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Editas Medicine, you can compare the effects of market volatilities on Sangamo Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Editas Medicine.
Diversification Opportunities for Sangamo Therapeutics and Editas Medicine
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sangamo and Editas is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Editas Medicine go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Editas Medicine
Given the investment horizon of 90 days Sangamo Therapeutics is expected to generate 2.33 times more return on investment than Editas Medicine. However, Sangamo Therapeutics is 2.33 times more volatile than Editas Medicine. It trades about 0.0 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.32 per unit of risk. If you would invest 204.00 in Sangamo Therapeutics on August 27, 2024 and sell it today you would lose (16.00) from holding Sangamo Therapeutics or give up 7.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sangamo Therapeutics vs. Editas Medicine
Performance |
| Timeline |
| Sangamo Therapeutics |
| Editas Medicine |
Sangamo Therapeutics and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sangamo Therapeutics and Editas Medicine
The main advantage of trading using opposite Sangamo Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |